Published in
American Society of Hematology, Blood, 2(132), p. 223-231
DOI: 10.1182/blood-2018-02-831289
Links
Tools
Hemostatic efficacy of pathogen-inactivated vs untreated platelets: a randomized controlled trial
Journal article published in 2018 by
Pieter F. van der Meer 
,
Paula F. Ypma,
Nan van Geloven ,
Joost A. van Hilten,
Rinie J. van Wordragen-Vlaswinkel,
Okke Eissen,
Jaap J. Zwaginga ,
Michael Trus,
Erik A. M. Beckers,
Peter te Boekhorst ,
Alan Tinmouth,
Yulia Lin ,
Cyrus Hsia ,
David Lee,
Philip J. Norris
and other authors.
,
Paula F. Ypma,
Nan van Geloven ,
Joost A. van Hilten,
Rinie J. van Wordragen-Vlaswinkel,
Okke Eissen,
Jaap J. Zwaginga ,
Michael Trus,
Erik A. M. Beckers,
Peter te Boekhorst ,
Alan Tinmouth,
Yulia Lin ,
Cyrus Hsia ,
David Lee,
Philip J. Norris
and other authors.
This paper was not found in any repository; the policy of its publisher is unknown or unclear.
Full text: Unavailable
Preprint: archiving forbidden
Published version:
archiving forbidden
Data provided by 
Abstract
Key Points Pathogen-inactivated platelets were noninferior in preventing bleeding only in intention-to-treat analysis. In contrast to animal models, alloimmunization could not be prevented when using pathogen-inactivated platelets.